Contact Us Product Guide Drug Information Site Map


Generic Business Strategies

Barr focuses generic development activities on generic versions of branded products that possess some combination of unique factors that have the effect of limiting competition. Such factors include difficult formulation, complex and costly manufacturing requirements or limited raw material availability. By targeting such products, the Company believes that its generic products will, in general, be less affected by the intense and rapid pricing pressure often associated with more commodity-type generic products. As a result, the Company’s generic products generally have few competitors or are able to enjoy longer periods of limited competition and thus generate profit margins higher than those often associated with commodity-type generic products.

> Unique Generic Products

> Patent Challenges

> New Technology Platforms

> Corporate Development

Generic Business Overview
Generic Business Strategies
•Unique Generic Products
•Patent Challenges
•New Technology Platforms
•Corporate Development
Key Generic Products
Generic Product Pipeline
Generic Sales Process
FAQ About Generics
FDA Approval Process
History of Generic Industry
Industry Links
Clinical Trials
Barr Pharmaceuticals, Inc. Terms of Use Legal Notice Privacy Policy